Publication | Closed Access

ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE−/− mice to attenuate vascular inflammation and increase plaque stability

InflammationVascular DiseaseCardiovascular DiseaseCell SignalingApoe−/− MicePlaque StabilityImmunologyPharmacologyChronic InflammationVascular InflammationVascular PharmacologyEndothelial DysfunctionVascular BiologyMedicineAtherosclerosisDyslipidemia